Orthocell Limited (H^CK account)
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Remplir™ Nerve Sparing Prostate Cancer Surgery Commercial Opportunity Gathers Momentum with ~100 Surgeries Now Performed with Multiple Surgeons Nationwide 2025-11-20 13:52
Remplir™ Study Delivers Compelling 81% Success Rate 2025-09-08 17:32
1